Össur hf: Transactions in relation to share buyback program
Announcement no. 18/2020
2 March 2020
Transactions in relation to share buyback program
On 17 February 2020, Össur hf. initiated a share buy-back program, see Company announcement no. 13/2020.
The purpose of the share buyback program was to reduce the Company's share capital and adjust the capital structure by distributing capital to shareholders in line with the Company's Capital Structure and Dividend Policy. The program would end no later than 31 May 2020. The Company could purchase up to 2,500,000 shares under the program, corresponding to 0.59% of the current share capital. The total consideration for shares purchased under the program should not exceed USD 5 million.
The following transactions have been made under the program in week 2, the period 24 February 2020 – 28 February 2020:
|Date||No. of shares||Avg. purchase
price in DKK
value in DKK
|24 February 2020||15,000||48.05||720,679|
|25 February 2020||14,252||46.15||657,778|
|26 February 2020||14,774||45.35||670,065|
|27 February 2020||15,974||45.31||723,769|
|28 February 2020||15,000||45.65||654,804|
Össur has acquired 139,450 shares under the program at the average price of DKK 47.35. Following the above transactions Össur’s holding of own shares is 3,554,250, corresponding to 0.84% of the Company’s total share capital.
The share buyback program on Nasdaq Copenhagen is carried out in accordance with Regulation No. 596/2014 of the European Parliament and of the Council on market abuse ("MAR"), and the Commission delegated regulation No. 2016/1052.
David Hreidarsson, Investor Relations, email@example.com, +354 515 1380
Helga Danielsdottir, Investor Relations, firstname.lastname@example.org, +354 515 1380
Össur press releases by e-mail
If you wish to receive Össur press releases by e-mail please register at http://www.ossur.com/investors
Össur (Nasdaq Copenhagen: OSSR) is a global leader in non-invasive orthopaedics that help people live a life without limitations. A recognized “Technology Pioneer,” Össur focuses on improving people’s mobility through the delivery of innovative technologies in Prosthetics and Bracing & Supports, by investing significantly in research and product development to create award-winning designs with consistently strong market positions. Successful patient and clinical outcomes are further empowered via Össur’s educational programs and business solutions. As part of Össur’s long-standing commitment to social responsibility, the company has been a signatory to the United Nations Global Compact since 2011, and also participates in the Nasdaq Nordic and Baltic exchanges’ voluntary guidelines for Environment, Social and Corporate Governance (ESG). Össur is headquartered in Iceland, with major operations in the Americas, Europe and Asia, and additional distributors worldwide. www.ossur.com